• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.70% Nasdaq Down0.25%

    Foundation Medicine, Inc. (FMI)

    48.14 Up 0.03(0.06%) 9:30AM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Foundation Medicine, Inc.
    150 Second Street
    Cambridge, MA 02141
    United States - Map
    Phone: 617-418-2200
    Fax: 617-418-2201
    Website: http://www.foundationmedicine.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:186

    Business Summary 

    Foundation Medicine, Inc. provides various molecular information products in the United States. Its molecular information platform generates actionable genomic information about a patient’s individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. The company offers clinical products, such as FoundationOne for solid tumors; and FoundationOne Heme, for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers. It has strategic collaboration agreement with WuXi PharmaTech (Cayman) Inc. to provide genomic profiling to biopharmaceutical companies conducting clinical trials; and F. Hoffmann-La Roche Ltd. to enhance the identification and development of novel treatment options for cancer patients. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Foundation Medicine, Inc.

    Corporate Governance 
    Foundation Medicine, Inc.’s ISS Governance QuickScore as of Jan 1, 2015 is 10. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 9; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Alexis Borisy A.M., 43
    Co-Founder, Chairman and Chairman of Compensation Committee
    Dr. Michael J. Pellini M.D., MBA, 49
    Chief Exec. Officer, Pres and Director
    Dr. Steven Kafka Ph.D., 46
    Chief Operating Officer
    Dr. Vincent A. Miller M.D., 53
    Chief Medical Officer
    Mr. Ronald D. Collette , 51
    Chief Information Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders